SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001811468-23-000002
Filing Date
2023-10-02
Accepted
2023-10-02 11:24:41
Documents
1
Effectiveness Date
2023-10-02
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 10710
  Complete submission text file 0001811468-23-000002.txt   11733
Mailing Address 8 DAVIS DRIVE, SUITE 300 DURHAM NC 27709
Business Address 8 DAVIS DRIVE, SUITE 300 DURHAM NC 27709 984-261-2001
Atsena Therapeutics, Inc. (Filer) CIK: 0001811468 (see all company filings)

IRS No.: 845181493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-493532 | Film No.: 231298406